LESLEY DELILLE: Open Payments
NPI 1972885903 · PAW PAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 26 payments from 10 companies in 2025. Trend: 2023 $863 · 2024 $1,465 · 2025 $805
Food & beverage: $775Long term medical supply or device loan: $30
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $163 |
| Axsome Therapeutics, Inc. | 3 | $161 |
| AstraZeneca Pharmaceuticals LP | 5 | $154 |
| Insulet Corporation | 1 | $127 |
| Novo Nordisk Inc | 4 | $81 |
| Abbott Laboratories | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Lundbeck LLC | 1 | $16 |
Products named: Auvelity, QULIPTA, Omnipod, AIRSUPRA, Ozempic, FARXIGA, FREESTYLE INSULINX, UBRELVY.
Industry payments across MI — which companies pay providers there.
